Soluble Hepatocyte Growth Factor (sHGF) and Vascular Endothelial Growth Factor (sVEGF) in Adult Acute Myeloid Leukemia: Relationship to Disease Characteristics

References

• Krause, J.R. (2000) "Morphology and classification of acute myeloid leukemia", In: Crisan, D., ed, Laboratory Medicine, Clinics of North America (VVB Saunders Company, UK), p 1.
   Google Scholar
• Sudhoff, T., Wehmeier, A., Kliche, K.O., Aul, C., Schlmer, P., Banser, U. and Schneider, W. (1996) "Levels of circulating endothelial adhesion molecules (sE-selectin and 5VCAM-1) in adult patients with acute leukemia", Leukemia 10(4), 682–686.
   PubMed Web of Science ®Google Scholar
• Hatzistilianon, M., Athanassiadou, F., Agguridki, C. and Catriu, D. (1997) "Circulating soluble adhesion molecule levels in children with acute lymphoblastic leukemia", Fur. J. Pediatr. 156(7), 537–540.
   Web of Science ®Google Scholar
• Lee, J.J., Chung, I.J., Park, MR., Ryang, D.W., Park, C.S. and Kim, H.J. (2001) "Increased angiogenesis and Fas-ligand expression are independent processes in acute myeloid leukemia", Leuk. Res. 25(12), 1067–1073.
   PubMed Web of Science ®Google Scholar
• Weimar, IS., Voermans, C., Bourhis, J.H., Miranda, N., Van den Berk, P.C., Nakamura, T., de Gast, G.C. and Gerritsen, W.R. (1998) "Hepatocyte growth factor/scatter factor (HGF/SF) affects proliferation and migration of myeloid leukemic cells", Leukemia 12(8), 1195–1203.
   PubMed Web of Science ®Google Scholar
• Mesters, R.M., Padro, T., Steins, M., Bieker, R., Retzlaff, S., Kessler, T., Kienast, J. and Berdel, W.E. (2001) "Angiogenesis in-patients with hematologic malignancies", Onkologie 24\(Suppl. 5), 75–80.
   PubMed Web of Science ®Google Scholar
• Folkmann, J. (1995) "Angiogenesis in cancer, vascular, rheumatoid and other disease", Nature 1, 27–31.
   Web of Science ®Google Scholar
• Aguayo, A., Kantarjian, H., Manshouri, T., Gidel, C., Estey, E., Thomas, D., Koller, C., Estrov, Z., O'Brien, S., Keating, M., Freireich, E. and Albitar, M. (2000) "Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes", Blood 96(6), 2240–2245.
   PubMed Web of Science ®Google Scholar
• Hjorth-Hansen, H., Seidel, C., Lamvik, J., Borset, M., Sundan, A. and Waage, A. (1999) "Elevated serum concentrations of hepatocyte growth factor in acute myelocytic leukemia", Fur. J. Hematol. 62(2), 129–134.
   PubMedGoogle Scholar
• Verstovesk, S., Kantarjian, H., Estey, E., Aguayo, A., Giles, F.J., Manshouri, T., Koller, C., Estrov, Z., Freireich, E., Keating, M. and Albitar, M. (2001) "Plasma hepatocyte growth is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome", Leukemia 15(8), 1165–1170.
   PubMed Web of Science ®Google Scholar
• Bellamy, W.T., Richter, L., Frutigar, Y. and Erogam, T.M. (1999) "Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies", Cancer Res. 59(3), 728–733.
   PubMed Web of Science ®Google Scholar
• Hussong, J.W., Rodgers, G.H. and Shami, P.J. (2000) "Evidence of increased angiogenesis in-patients with acute myeloid leukemia", Blood 95(1), 309–313.
   PubMed Web of Science ®Google Scholar
• Katoh, O., Tauchi, H., Kawaishi, K., Kimura, A. and Satow, Y. (1995) "Expression of vascular endothelial growth factor (VEGF) receptor gene, KDR, in hemopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation", Cancer Res. 55, 5687–5692.
   PubMed Web of Science ®Google Scholar
• Fiedler, W., Graeven, U., Ergun, S., Verago, S., Kilic, N., Stochschlader, M. and Hossfeld, K.D. (1997) "Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia", Blood 89(6), 1870–1875.
   PubMed Web of Science ®Google Scholar
• Ratajczak, M.Z., Ratajczak, J., Machalinski, B., Majka, M., Marlicz, W., Carter, A., Pietzkowski, Z. and Gewirtz, A.M. (1998) "Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (PIGF) in regulating human hematopoietic cell growth", Br. J. Hematol. 103, 969–979.
   PubMed Web of Science ®Google Scholar
• Aguayo, A., Estey, E., Kantarjian, H., Manouri, T., Gidel, C., Keating, M., Giles, F., Estrov, Z., Barlogie, B. and Albitar, M. (1999) "Cellular vascular endothelial growth factor is a predictor of patient outcome in patients with acute myeloid leukemia", Blood 94(11), 3717–3721.
   PubMed Web of Science ®Google Scholar
• Atitalo, R.L., Mustjoki, S., Elonen, E., Helminen, P. and Jansson, S.-E. (1999) "Endothelial growth factors and their receptors in human leukemia (Abstract)", Blood 94, 70a.
   Web of Science ®Google Scholar
• Dias, S., Lane, W.J., Wu, Y., Choy, M., Peichev, M., Chadburn, A., Hyjeck, E., Roboz, G., Hicklin, D., Witte, L. and Rafii, S. (1999) "Neutralizing MoAb to VEGF receptors inhibit proliferation and migration of a subset of human leukemias through interaction with VEGR-2 (KDR) and VEGFR-1 (FLT-1) (Abstract)", Blood 94, 620a.
   Web of Science ®Google Scholar
• Pruneri, G., Bertolini, F., Soligo, D., Carboni, N., Cortelezzi, P.F., Buffa, R., Lambertenghi-Deliers, G. and Pezzella, F. (1999) "Angiogensis in myelodysplastic syndromes", Br. J. Cancer 81, 1398–1401.
   PubMed Web of Science ®Google Scholar
• Koistinen, P., Siitonen, T., Mantymaa, P., Saily, M., Kinnula, V, Savolainen, E.R. and Soini, Y. (2001) "Regulation of the acute myeloid leukemia cell line OCl/AML-2 by endothelial nitric oxide synthase under the control of vascular endothelial growth factor signaling system", Leukemia 15(9), 1433–1441.
   PubMed Web of Science ®Google Scholar
• Beilmann, M., Odenthal, M., Jung, W., Vande Woude, C.F., Dienes, H.P. and Schirmacher, P. (1997) "Neo-expression of c-met/hepatocyte growth factor—scatter factor receptor gene in activated monocytes", Blood 90(11), 4450–4458.
   PubMed Web of Science ®Google Scholar
• Dias, S., Shmelkov, S.V., Lam, G. and Rafii, S. (2002) "VEGF(165) promotes survival of leukemic cells by Hsp 90-mediated induction of BCL-2 expression and apoptosis inhibition", Blood 99(7), 2532–2540.
   PubMed Web of Science ®Google Scholar
• Foss, B., Mentzoni, L. and Bruserud, O. (2001) "Effects of vascular endothelial growth factor on acute myelogenous leukemia blasts", J. Hematother. Stem Cell Res. 10(1), 81–93.
   PubMedGoogle Scholar
• Smolich, B.D., Yuen, H.A., West, K.A., Giles, F.J., Albitar, M. and Cherrington, J.M. (2001) "The anti angiogenic protein kinase inhibitors 5U5416 and SU 6668 inhibit the SCF receptor (C-kit) in human myeloid leukemia cell line and in acute myeloid leukemia blasts", Blood 97(5), 1413–1421.
   PubMed Web of Science ®Google Scholar
• Jeha, S., Smith, F.O., Estey, E., Shen, Y., Liu, D., Manshouri, T. and Albitar, M. (2002) "Comparison between pediatric acute myeloid leukemia (AML) and adult AML in VEGF and KDR (VEGF-R2) protein levels", Leuk. Res. 26(4), 399–402.
   PubMed Web of Science ®Google Scholar
• Watarai, M., Miwa, H., Shikami, M., Sugamura, K., Wakabasyashi, M., Satoh, A., Tsuboi, K., Imamura, A., Mihara, H., Katoh, Y., Kita, K. and Nitta, M. (2002) "Expression of endothelial cell associated molecules in AML cells", Leukemia 16(1), 112–119.
   PubMed Web of Science ®Google Scholar
• Jiang, W., Hiscox, S., Matsumoto, K. and Nakamura, T. (1999) "Hepatocyte growth factor/scatter factor, is molecular, cellular and clinical implications in Cancer", Crit. Rev. Oncol. Hematol. 29, 209–248.
   PubMed Web of Science ®Google Scholar
• Roletto, F., Galavani, A.P., Cristiani, C., Valasasina, B., Landonio, A. and Bertolero, F. (1996) "Basic fibroblastic growth factor stimulates hepatocyte growth factor/scatter factor secretion by human mesenchymal cells", J. Cell Physiol. 166, 105–111.
   PubMed Web of Science ®Google Scholar
• Van Belle, E., Witzenbichler, B., Chen, D., Silver, M., Chang, L., Schwall, R. and Isner, J.M. (1998) "Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelia growth factor: the case for paracrine amplification of angiogenesis", Circulation 97, 381–390.
   PubMed Web of Science ®Google Scholar
• Fuhrmann-Bezakein, E., Ma, M.N., Rubbia-Brandt, L., Mentha, G., Ruefenacht, D., Sappino, A.P. and Pepper, M.S. (2000) "Elevated levels of angiogenic cytokines in the plasma of cancer patients", Int. J. Cancer 85, 40–45.
   PubMed Web of Science ®Google Scholar
• Sakon, M., Kita, Y, Takeda, Y., Higaki, N., Ohazato, H., Umeshita, K., Hasuike, Y. and Gotoh, M. (1999) "Measure-ment of hepatocyte growth factor in serum and plasma", Int. J. Clin. Lab. Res. 29, 110–113.
   PubMedGoogle Scholar
• Banks, R.E., Forbes, M.A., Kinsey, SE., Stanley, A., Ingham, E., Walters, C. and Selby, P.J. (1998) "Release of angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology", Br. J. Cancer 77, 956–964.
   PubMed Web of Science ®Google Scholar
• Russell, W.E., Mc Cowan, J.A. and Bucher, N.L. (1984) "Partial characterization of a hepatocyte growth factor from rat platelets", J. Cell Physiol. 119, 183–192.
   PubMed Web of Science ®Google Scholar
• Strain, A.J., Mc Cowan, J.A. and Bucher, N.L. (1982) "Stimulation of DNA synthesis in primary cultures of adult rat hepatocytes by rat platelet-associated substance(s) in vitro", 18, 108–116.
   Google Scholar